News
Temixys Approved for the Treatment of HIV-1 Infection
Temixys combines lamivudine (3TC) and tenofovir disoproxil fumarate (TDF), which are 2 nucleoside reverse transcriptase inhibitors.
Your search for esrd returned 29 results
ACR/ARHP 2018 Annual Meeting
Obesity Negatively Affects Treatment Response to JAK Inhibitors in RA
Patients treated with JAK inhibitors for rheumatoid arthritis may be less likely to have low disease activity if they are obese compared with those who are overweight.
News
New Staging System Predicts CKD Progression in Children
"CKD staged by level of eGFR and proteinuria characterizes the timeline of progression and can guide management strategies in children," the authors write.
News
Uric Acid-Lowering Therapy May Improve Renal Outcomes in CKD Patients
Uric acid-lowering therapy might improve kidney outcomes, including kidney failure events, proteinuria, and the rate of change in eGFR, and seem to reduce the risk of cardiovascular events in adults with CKD.
News
Sleep Duration, Quality Tied to Chronic Kidney Disease Progression
Shorter sleep duration, greater sleep fragmentation linked to greater decline in eGFR
News
RRT Initiation Impacts Health-Related Quality of Life in ESRD
Total of 26.6 and 27 percent of patients experienced anxiety, depression with initiation of RRT
News
Systolic BP Variability Linked to Increased Risk of Death, Morbidity
Increased SBP variability tied to mortality, coronary heart disease, stroke, end-stage renal disease
News
Analysis Identifies Uveitis Risk Factors in Ankylosing Spondylitis Patients
An analysis published in Medicine identified hip-joint lesion, prevalence of peripheral arthritis, and antistreptolysin O (ASO) and circulating immune complex (CIC) levels as risk factors that may be tied to higher rates of uveitis in ankylosing spondylitis.
News
Higher Allopurinol Dose May be Nephroprotective in Elderly
A higher allopurinol dose provided a protective effect against incident renal failure in elderly patients, according to a study published in Annals of the Rheumatic Diseases.
Drug News
Tocilizumab Shows Superiority in RA Patients After Non-TNFi Failure
For patients with rheumatoid arthritis (RA) and a first non-tumor necrosis factor inhibitor (TNFi) failure, treatment with tocilizumab seems more efficacious than abatacept or rituximab
